This research study aims to determine what effects (good and bad) Durvalumab has on participants and their cancer with a "quick start" of Durvalumab within 14 …

Nonsmall Cell Lung Cancer Stage IIIUnresectable Non-Small Cell Lung CarcinomaNonsmall Cell Lung Cancer, Stage II

~Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT05696782

Phase 2

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance in Non-Squamous Locally Advanced Non-Small Cell Lung Cancer

The purpose of this research is to see if monitoring the brain using magnetic resonance imaging (MRI) after radiation therapy will allow investigators to find …

Brain MetastasesNonsmall Cell Lung Cancer Stage III

~Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT05692635